Maravai LifeSciences Holdings, Inc. (MRVI)

NASDAQ: MRVI · IEX Real-Time Price · USD
7.76
-0.39 (-4.73%)
Apr 17, 2024, 3:36 PM EDT - Market open
-4.73%
Market Cap 1.03B
Revenue (ttm) 288.95M
Net Income (ttm) -119.03M
Shares Out 132.31M
EPS (ttm) -0.90
PE Ratio n/a
Forward PE 30.40
Dividend n/a
Ex-Dividend Date n/a
Volume 1,294,915
Open 8.19
Previous Close 8.14
Day's Range 7.68 - 8.30
52-Week Range 4.52 - 16.62
Beta 0.01
Analysts Buy
Price Target 11.56 (+49.07%)
Earnings Date May 8, 2024

About MRVI

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in tw... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Nov 20, 2020
Employees 650
Stock Exchange NASDAQ
Ticker Symbol MRVI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for MRVI stock is "Buy." The 12-month stock price forecast is $11.56, which is an increase of 49.07% from the latest price.

Price Target
$11.56
(49.07% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024

SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans ...

6 days ago - GlobeNewsWire

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to ...

5 weeks ago - GlobeNewsWire

Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results

Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation

7 weeks ago - GlobeNewsWire

Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024

SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t...

2 months ago - GlobeNewsWire

Maravai LifeSciences Announces November 2023 Investor Conference Schedule

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to p...

5 months ago - GlobeNewsWire

Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023

SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t...

6 months ago - GlobeNewsWire

Maravai LifeSciences Hosts 2023 Investor R&D Day

Highlights include the company's strong foundation for growth, focus on innovation and attractive long-term outlook Highlights include the company's strong foundation for growth, focus on innovation a...

7 months ago - GlobeNewsWire

Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100

SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced ...

7 months ago - GlobeNewsWire

Maravai LifeSciences to Host 2023 Investor R&D Day

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovator...

8 months ago - GlobeNewsWire

Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit

LELAND, N.C., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading product and services provider for the detection and characteriza...

8 months ago - GlobeNewsWire

Maravai LifeSciences Announces August 2023 Investor Conference Schedule

SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to p...

8 months ago - GlobeNewsWire

Maravai LifeSciences Reports Second Quarter 2023 Financial Results

Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation

9 months ago - GlobeNewsWire

Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition

GlobeNewswire window.initGradientEffect = function () { } document.addEventListener('DOMContentLoaded', function () { const extendedTableZoomElements = document.querySelectorAll('.extended-table-zoom'...

9 months ago - GlobeNewsWire

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023

SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators...

9 months ago - GlobeNewsWire

Maravai LifeSciences Announces Appointment of New Director to the Board

SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and...

9 months ago - GlobeNewsWire

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023

SAN DIEGO, April 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans ...

1 year ago - GlobeNewsWire

Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report

- Highlights progress across five priority areas focused on building a foundation for sustainable growth.

1 year ago - GlobeNewsWire

Maravai LifeSciences Announces March 2023 Investor Conference Schedule

SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to ...

1 year ago - GlobeNewsWire

Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results

Base business revenues, excluding COVID-19 related CleanCap® revenues, were up 67% in the fourth quarter and up 17% for the full year

1 year ago - GlobeNewsWire

Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023

SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t...

1 year ago - GlobeNewsWire

Maravai LifeSciences Announces Updated CEO Leadership Transition Plans

Maravai announces plans for William “Trey” Martin, III to serve as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai's CEO in July 2023

1 year ago - GlobeNewsWire

Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America

SAN DIEGO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced i...

1 year ago - GlobeNewsWire

New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing

SOUTHPORT, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Cygnus Technologies , part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and services provider for the detection and characteri...

1 year ago - GlobeNewsWire

Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation

Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit

1 year ago - GlobeNewsWire

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022

SAN DIEGO, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t...

1 year ago - GlobeNewsWire